Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             188 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysis Shree, Tanaya

1 p. 130-142
artikel
2 ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura Sakai, Kazuya

1 p. 131-140
artikel
3 Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment Serra, Sara

1 p. 47-61
artikel
4 Allogeneic hematopoietic stem cell transplantation in leukocyte adhesion deficiency type I and III Bakhtiar, Shahrzad

1 p. 262-273
artikel
5 100 Already? Negrin, Robert S.

1 p. 274
artikel
6 A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry Du, Zhaohui

1 p. 181-190
artikel
7 A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia Al-Samkari, Hanny

1 p. 9-18
artikel
8 Analysis of baseline circulating tumor cells integrated with PET/CT findings in transplant-ineligible multiple myeloma Ikeda, Daisuke

1 p. 37-46
artikel
9 An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia Ragaini, Simone

1 p. 87-99
artikel
10 An update on the molecular pathogenesis and potential therapeutic targeting of AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1 Al-Harbi, Sayer

1 p. 229-238
artikel
11 A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease Lazaryan, Aleksandr

1 p. 259-269
artikel
12 A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant Dandoy, Christopher E.

1 p. 1-11
artikel
13 A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study Visco, Carlo

1 p. 327-338
artikel
14 A robust approach for the generation of functional hematopoietic progenitor cell lines to model leukemic transformation Doma, Eszter

1 p. 39-53
artikel
15 ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease James, Paula D.

1 p. 280-300
artikel
16 ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease Connell, Nathan T.

1 p. 301-325
artikel
17 Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 study Lynggaard, Line Stensig

1 p. 138-147
artikel
18 Assessment of health-related quality of life among adults hospitalized with sickle cell disease vaso-occlusive crisis Esham, Kimberly S.

1 p. 19-27
artikel
19 Assessment of HLA-B genetic variation with an HLA-B leader tool and implications in clinical transplantation Sajulga, Ray

1 p. 270-280
artikel
20 Association of allele-specific methylation of the ASNS gene with asparaginase sensitivity and prognosis in T-ALL Akahane, Koshi

1 p. 212-224
artikel
21 A systematic review of antithrombotic treatment of venous thromboembolism in patients with myeloproliferative neoplasms Hamulyák, Eva N.

1 p. 113-121
artikel
22 Bortezomib-based antibody depletion for refractory autoimmune hematological diseases Ratnasingam, Sumita

1 p. 31-35
artikel
23 Bruscaggin A, Terzi di Bergamo L, Spina V, et al. Circulating tumor DNA for comprehensive noninvasive monitoring of lymphoma treated with ibrutinib plus nivolumab. Blood Adv. 2021;5(22):4674-4685.
1 p. 159-161
artikel
24 Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults Lin, Richard J.

1 p. 12-20
artikel
25 CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216 Gress, Verena

1 p. 112-129
artikel
26 CD61 identifies a superior population of aged murine HSCs and is required to preserve quiescence and self-renewal Skinder, Natalia

1 p. 99-111
artikel
27 CD36 regulates factor VIII secretion from liver endothelial cells Reventun, Paula

1 p. 143-149
artikel
28 Characterizing epigenetic aging in an adult sickle cell disease cohort Lê, Brandon M.

1 p. 47-55
artikel
29 Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells Lim, Karen Phaik Har

1 p. 87-99
artikel
30 Clinical diagnostics and treatment strategies for Philadelphia chromosome–like acute lymphoblastic leukemia Harvey, Richard C.

1 p. 218-228
artikel
31 Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial Hamadani, Mehdi

1 p. 93-98
artikel
32 Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection Minniti, Caterina P.

1 p. 207-215
artikel
33 Clinical response to larotrectinib in adult Philadelphia chromosome–like ALL with cryptic ETV6-NTRK3 rearrangement Nardi, Valentina

1 p. 106-111
artikel
34 Clinicopathological features of adult T-cell leukemia/lymphoma with HTLV-1–infected Hodgkin and Reed-Sternberg–like cells Karube, Kennosuke

1 p. 198-206
artikel
35 Comparing super-utilizers and lower-utilizers among commercial- and Medicare-insured adults with sickle cell disease MacEwan, Sarah R.

1 p. 224-233
artikel
36 Concizumab: a novel anti-TFPI therapeutic for hemophilia Shapiro, Amy D.

1 p. 279
artikel
37 Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists Stojkov, Igor

1 p. 1-12
artikel
38 Creating an international network for science and clinical progress: democratizing dissemination of advances in global hematology Kean, Leslie S.

1 p. 275-276
artikel
39 Deciphering racial disparities in multiple myeloma outcomes Bertrand, Kimberly A.

1 p. 234-235
artikel
40 Deep learning predicts therapy-relevant genetics in acute myeloid leukemia from Pappenheim-stained bone marrow smears Kockwelp, Jacqueline

1 p. 70-79
artikel
41 Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplant Nauffal, Mary

1 p. 181-188
artikel
42 Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies Bagratuni, Tina

1 p. 189-199
artikel
43 Differential roles of factors IX and XI in murine placenta and hemostasis under conditions of low tissue factor Grover, Steven P.

1 p. 207-216
artikel
44 Distinguishing STAT3/STAT5B-mutated large granular lymphocyte leukemia from myeloid neoplasms by genetic profiling Kavesh, Mark

1 p. 40-45
artikel
45 Dual inhibition of the MEK/ERK and PI3K/AKT pathways prevents pulmonary GVHD suppressing perivenulitis and bronchiolitis Muranushi, Hiroyuki

1 p. 106-121
artikel
46 Dynamic changes in murine erythropoiesis from birth to adulthood: implications for the study of murine models of anemia Chen, Lixiang

1 p. 16-25
artikel
47 Eμ and 3′RR transcriptional enhancers of the IgH locus cooperate to promote c-myc–induced mature B-cell lymphomas Ghazzaui, Nour

1 p. 28-39
artikel
48 Early and late outcomes after cord blood transplantation for pediatric patients with inherited leukodystrophies van den Broek, Brigitte T.A.

1 p. 49-60
artikel
49 Early FDG-PET response predicts CAR-T failure in large B-cell lymphoma Kuhnl, Andrea

1 p. 321-326
artikel
50 Editorial Board
1 p. i
artikel
51 Editorial Board
1 p. i
artikel
52 Editorial Board
1 p. i
artikel
53 Editorial Board
1 p. i
artikel
54 Editorial Board
1 p. i
artikel
55 Editorial Board
1 p. i
artikel
56 Editorial Board
1 p. i
artikel
57 Exosomal regulation of lymphocyte homing to the gut Park, Eun Jeong

1 p. 1-11
artikel
58 Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas Liu, Xia

1 p. 141-153
artikel
59 Extended clinical and genetic spectrum associated with biallelic RTEL1 mutations Touzot, Fabien

1 p. 36-46
artikel
60 Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice Kattula, Sravya

1 p. 25-35
artikel
61 First description of the t(3;17)(q27;q21)/IGF2BP2::LSM12 translocation in marginal zone lymphoma Diez-Feijóo, Ramón

1 p. 162-166
artikel
62 Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma Santoro, Armando

1 p. 136-140
artikel
63 Fluorescent labeling of CRISPR/Cas9 RNP for gene knockout in HSPCs and iPSCs reveals an essential role for GADD45b in stress response Nasri, Masoud

1 p. 63-71
artikel
64 Front Matter
1 p. ii
artikel
65 Genetic and immunohistochemical profiling of NK/T-cell lymphomas reveals prognostically relevant BCOR-MYC association Oishi, Naoki

1 p. 178-189
artikel
66 Geographic prevalence variation and phenotype penetrance in porphyria: insights from a Chinese population database Li, Pei

1 p. 12-15
artikel
67 Glycophorin-C sialylation regulates Lu/BCAM adhesive capacity during erythrocyte aging Klei, T.R.L.

1 p. 14-24
artikel
68 Goldmann L, Duan R, Kragh T, et al. Oral Bruton tyrosine kinase inhibitors block activation of the platelet Fc receptor CD32a (FcγRIIA): a new option in HIT? Blood Adv. 2019;3(23):4021-4033.
1 p. 112
artikel
69 Granulocytic myeloid-derived suppressor cells to prevent and treat murine immune-mediated bone marrow failure Feng, Xingmin

1 p. 73-86
artikel
70 GRK6 regulates the hemostatic response to injury through its rate-limiting effects on GPCR signaling in platelets Chen, Xi

1 p. 76-86
artikel
71 Gynecologic and obstetric management of women with von Willebrand disease: summary of 3 systematic reviews of the literature Brignardello-Petersen, Romina

1 p. 228-237
artikel
72 Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia Wieduwilt, Matthew J.

1 p. 339-357
artikel
73 Hematologic complications with age in Shwachman-Diamond syndrome Furutani, Elissa

1 p. 297-306
artikel
74 Hematologic indices in individuals with pathogenic germline DICER1 variants Vasta, Lauren M.

1 p. 216-223
artikel
75 Hemoglobin variants identified in the Uganda Sickle Surveillance Study Schaefer, Beverly A.

1 p. 93-100
artikel
76 Hereditary folate malabsorption due to a mutation in the external gate of the proton-coupled folate transporter SLC46A1 Aluri, Srinivas

1 p. 61-68
artikel
77 Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms Marsh, Judith C.W.

1 p. 36-48
artikel
78 HIGH-2-LOW risk model to predict venous thromboembolism in allogeneic transplant patients after platelet engraftment Martens, Kylee L.

1 p. 167-175
artikel
79 Humoral response to mRNA anti–COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia Bagacean, Cristina

1 p. 207-211
artikel
80 Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C Cornish, Alex J.

1 p. 21-32
artikel
81 Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma Baird, John H.

1 p. 143-155
artikel
82 Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma Liang, Zhiyu

1 p. 293-296
artikel
83 Impact of CMV reactivation on relapse of acute myeloid leukemia after HCT is dependent on disease stage and ATG Turki, Amin T.

1 p. 28-36
artikel
84 Impact of treatment effect on MRD and PFS: an aggregate data analysis from randomized clinical trials in multiple myeloma Paiva, Bruno

1 p. 219-223
artikel
85 Impaired formation of neutrophil extracellular traps in patients with MDS Brings, Carolin

1 p. 129-137
artikel
86 Implementation of hospital-based sickle cell newborn screening and follow-up programs in Haiti Alvarez, Ofelia A.

1 p. 14-22
artikel
87 Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15 Fernandez, Rafael Alonso

1 p. 9-19
artikel
88 Inducible Sbds deletion impairs bone marrow niche capacity to engraft donor bone marrow after transplantation Zha, Ji

1 p. 108-120
artikel
89 Inhibition of B-cell receptor signaling disrupts cell adhesion in mantle cell lymphoma via RAC2 Wu, Wenjun

1 p. 185-197
artikel
90 Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia Wynne, Joseph

1 p. 96-104
artikel
91 Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia Simoes, Catia

1 p. 167-173
artikel
92 Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysis Chai, Khai Li

1 p. 20-31
artikel
93 Iron status influences the response of cord blood megakaryocyte progenitors to eltrombopag in vitro Liu, Zhi-Jian

1 p. 13-27
artikel
94 Isoquercetin for thromboinflammation in sickle cell disease: a randomized double-blind placebo-controlled trial Lizarralde-Iragorri, Maria A.

1 p. 172-182
artikel
95 JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1β Yan, Yuhan

1 p. 200-206
artikel
96 KAT2A complexes ATAC and SAGA play unique roles in cell maintenance and identity in hematopoiesis and leukemia Arede, Liliana

1 p. 165-180
artikel
97 Kini Bailur J, Mehta S, Zhang L, et al. Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy. Blood Adv. 2017;1(25):2343-2347.
1 p. 75
artikel
98 Lin28b regulates age-dependent differences in murine platelet function Stolla, Massiel Chavez

1 p. 72-82
artikel
99 Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia Robbins, Daniel J.

1 p. 80-92
artikel
100 Longitudinal effect of disease-modifying therapy on tricuspid regurgitant velocity in children with sickle cell anemia Rai, Parul

1 p. 89-98
artikel
101 Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutations Zhang, Haiyu

1 p. 190-194
artikel
102 Low VWF levels in children and lack of association with bleeding in children undergoing tonsillectomy Gill, Joan Cox

1 p. 100-105
artikel
103 Management and follow-up of pregnancy-onset thrombotic thrombocytopenic purpura: the French experience Béranger, Nicolas

1 p. 183-193
artikel
104 Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma Illidge, Tim M.

1 p. 203-206
artikel
105 Medullary stromal cells synergize their production and capture of CCL21 for T-cell emigration from neonatal mouse thymus James, Kieran D.

1 p. 99-112
artikel
106 Megadose 90Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphoma Chow, Victor A.

1 p. 37-45
artikel
107 Membrane curvature and PS localize coagulation proteins to filopodia and retraction fibers of endothelial cells Carman, Christopher V.

1 p. 60-72
artikel
108 Metabolic syndrome increases risk of venous thromboembolism recurrence after acute deep vein thrombosis Stewart, Lauren K.

1 p. 127-135
artikel
109 microRNA-22 promotes megakaryocyte differentiation through repression of its target, GFI1 Weiss, Cary N.

1 p. 33-46
artikel
110 MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen Ali, Haris

1 p. 83-95
artikel
111 Modulation of IL-6/STAT3 signaling axis in CD4+FOXP3− T cells represents a potential antitumor mechanism of azacitidine Lamprianidou, Eleftheria

1 p. 129-142
artikel
112 MRI predicts 5-year joint bleeding and development of arthropathy on radiographs in hemophilia Foppen, Wouter

1 p. 113-121
artikel
113 Navigating a new terrain: how Twitter is changing hematologists Zaidi, Ahmar U.

1 p. 277-278
artikel
114 Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia Shimony, Shai

1 p. 23-36
artikel
115 New developments in the management of sickle cell disease Thompson, Alexis A.

1 p. 3
artikel
116 Notch activation is pervasive in SMZL and uncommon in DLBCL: implications for Notch signaling in B-cell tumors Shanmugam, Vignesh

1 p. 71-83
artikel
117 Obesity and neoplasms of lymphohematopoietic cells Lichtman, Marshall A.

1 p. 101-103
artikel
118 Orally bioavailable BTK PROTAC active against wild-type and C481 mutant BTKs in human lymphoma CDX mouse models Lim, Ye Seul

1 p. 92-105
artikel
119 Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium Trials Valtis, Yannis K.

1 p. 72-81
artikel
120 Overcoming resistance to targeted therapies in chronic lymphocytic leukemia Skånland, Sigrid S.

1 p. 334-343
artikel
121 PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation Frigault, Matthew J.

1 p. 122-126
artikel
122 Phosphoproteomics and morphology of stored human red blood cells treated by protein tyrosine phosphatases inhibitor Bardyn, Manon

1 p. 1-13
artikel
123 Piezo1-xerocytosis red cell metabolome shows impaired glycolysis and increased hemoglobin oxygen affinity Kiger, Laurent

1 p. 84-88
artikel
124 Plasma fibrinolysis, inflammatory markers, and postthrombotic syndrome: preliminary findings from the Kids-DOTT Biobank Betensky, Marisol

1 p. 233-239
artikel
125 Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism Edvardsen, Magnus S.

1 p. 224-232
artikel
126 Platelet α-granules contribute to organ-specific pathologies in a mouse model of severe malaria Darling, Thayer K.

1 p. 1-8
artikel
127 Platelets and hemostasis: a new perspective on an old subject Brass, Lawrence F.

1 p. 5-9
artikel
128 Platelets as immune-sensing cells Kapur, Rick

1 p. 10-14
artikel
129 Polarized mitochondria as guardians of NK cell fitness Surace, Laura

1 p. 26-38
artikel
130 Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopenia Cines, Douglas B.

1 p. 62-74
artikel
131 Postibrutinib relapse outcomes for patients with marginal zone lymphoma Epperla, Narendranath

1 p. 88-91
artikel
132 Pre-HCT mosaicism increases relapse risk and lowers survival in acute lymphoblastic leukemia patients post–unrelated HCT Wang, Yiwen

1 p. 66-70
artikel
133 Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups Shah, Urvi A.

1 p. 236-247
artikel
134 Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia Wakita, Satoshi

1 p. 238-247
artikel
135 Prognostic significance of cytogenetic heterogeneity in patients with newly diagnosed multiple myeloma Merz, Maximilian

1 p. 1-9
artikel
136 Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11 Ishikawa, Yuichi

1 p. 66-75
artikel
137 Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy Peres, Lauren C.

1 p. 251-259
artikel
138 Real-life experience with CPX-351 and impact on the outcome of high-risk AML patients: a multicentric French cohort Chiche, Edmond

1 p. 176-184
artikel
139 Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination Valsecchi, Carla

1 p. 174-177
artikel
140 Refined National Institutes of Health response algorithm for chronic graft-versus-host disease in joints and fascia Inamoto, Yoshihiro

1 p. 40-46
artikel
141 Resistance to PRMT5-targeted therapy in mantle cell lymphoma Long, Mackenzie Elizabeth

1 p. 150-163
artikel
142 Risk of posthospital venous thromboembolism in patients with COVID-19 varies by SARS-CoV-2 period and vaccination status Roubinian, Nareg H.

1 p. 141-144
artikel
143 Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin Politikos, Ioannis

1 p. 191-202
artikel
144 Seidizadeh O, Baronciani L, Pagliari MT, et al. Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2. Blood Adv. 2022; 6(13):4031-4040.
1 p. 87
artikel
145 Should we avoid heparin to eliminate HIT? Arepally, Gowthami Morey

1 p. 4
artikel
146 Shrinking the divide: improving myeloma CART access Nooka, Ajay K.

1 p. 248-250
artikel
147 Six-month antibody persistence after BNT162b2 mRNA COVID-19 vaccination in patients with chronic lymphocytic leukemia Herishanu, Yair

1 p. 148-151
artikel
148 Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults Johnston, Hannah

1 p. 164-171
artikel
149 Somatic GATA2 mutations define a subgroup of myeloid malignancy patients at high risk for invasive fungal disease Vedula, Rahul S.

1 p. 54-60
artikel
150 Structural analysis of platelet fragments and extracellular vesicles produced by apheresis platelets during storage De Paoli, Silvia H.

1 p. 207-218
artikel
151 Successful treatment with fingolimod of graft-versus-host disease of the central nervous system Gauthier, Jordan

1 p. 10-13
artikel
152 Supramaximal calcium signaling triggers procoagulant platelet formation Abbasian, Nima

1 p. 154-164
artikel
153 Surgical management of patients with von Willebrand disease: summary of 2 systematic reviews of the literature Brignardello-Petersen, Romina

1 p. 121-128
artikel
154 Systemic multilineage engraftment in mice after in utero transplantation with human hematopoietic stem cells Witt, Russell G.

1 p. 69-74
artikel
155 Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunities Morgan, Elizabeth A.

1 p. 84-92
artikel
156 Targeted deep sequencing in polycythemia vera and essential thrombocythemia Tefferi, Ayalew

1 p. 21-30
artikel
157 Targeting ubiquitin-activating enzyme induces ER stress–mediated apoptosis in B-cell lymphoma cells Best, Scott

1 p. 51-62
artikel
158 Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 study Oleshko, Olga

1 p. 122-130
artikel
159 TA-TMA: state of the art for diagnosis and treatment Dvorak, Christopher C.

1 p. 217
artikel
160 αβ T-cell graft depletion for allogeneic HSCT in adults with hematological malignancies de Witte, Moniek A.

1 p. 240-249
artikel
161 TCRαβ/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders Merli, Pietro

1 p. 281-292
artikel
162 Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation Frerichs, Kristine A.

1 p. 194-206
artikel
163 TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes Gurnari, Carmelo

1 p. 100-107
artikel
164 The binding of autotaxin to integrins mediates hyperhomocysteinemia-potentiated platelet activation and thrombosis in mice and humans Han, Lulu

1 p. 46-61
artikel
165 The fragility index in 2010-2021 chronic lymphocytic leukemia randomized controlled trials Bagacean, Cristina

1 p. 225-227
artikel
166 The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia Sun, Clare

1 p. 145-158
artikel
167 The incidence of cancer-associated thrombosis is increasing over time Mahajan, Anjlee

1 p. 307-320
artikel
168 The metabolic reprogramming in acute myeloid leukemia patients depends on their genotype and is a prognostic marker Lo Presti, Caroline

1 p. 156-166
artikel
169 The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia Cunningham, Alan

1 p. 56-69
artikel
170 Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura Zheng, Liang

1 p. 75-83
artikel
171 The severe spontaneous bleeding phenotype in a novel hemophilia A rat model is rescued by platelet FVIII expression Shi, Qizhen

1 p. 55-65
artikel
172 The use of luspatercept for thalassemia in adults Cappellini, Maria Domenica

1 p. 326-333
artikel
173 Toxicity and efficacy of CAR T-cell therapy in primary and secondary CNS lymphoma: a meta-analysis of 128 patients Cook, Michael R.

1 p. 32-39
artikel
174 Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression Stratmann, Svea

1 p. 152-164
artikel
175 Treatment of congenital thrombocytopenia and decreased collagen reactivity in G6b-B–deficient mice Mazharian, Alexandra

1 p. 46-59
artikel
176 Treatment of refractory hemophagocytic lymphohistiocytosis with emapalumab despite severe concurrent infections Lounder, Dana T.

1 p. 47-50
artikel
177 Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCT Badar, Talha

1 p. 47-54
artikel
178 Truncation of 3′ CCND1 by t(11;22) leads to negative SP4 CCND1 immunohistochemistry in blastoid mantle cell lymphoma Maekawa, Fumiyo

1 p. 61-65
artikel
179 Tryptophan metabolism is dysregulated in individuals with Fanconi anemia Bartlett, Allison L.

1 p. 250-261
artikel
180 U2AF1 and EZH2 mutations are associated with nonimmune hemolytic anemia in myelodysplastic syndromes Komrokji, Rami

1 p. 1-8
artikel
181 UCD with MCD-like inflammatory state: surgical excision is highly effective Zhang, Miao-yan

1 p. 122-128
artikel
182 Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months Lew, Thomas E.

1 p. 165-173
artikel
183 Upregulation of cAMP prevents antibody-mediated thrombus formation in COVID-19 Zlamal, Jan

1 p. 248-258
artikel
184 von Willebrand factor binding to myosin assists in coagulation Flood, Veronica H.

1 p. 174-180
artikel
185 von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis Kalot, Mohamad A.

1 p. 62-71
artikel
186 Welcome to Blood Advances Negrin, Robert S.

1 p. 1
artikel
187 Worse outcome and distinct mutational pattern in follicular lymphoma with anti-HBc positivity Fernández-Rodríguez, Concepción

1 p. 82-86
artikel
188 YY1 controls Eμ-3′RR DNA loop formation and immunoglobulin heavy chain class switch recombination Mehra, Parul

1 p. 15-20
artikel
                             188 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland